Erika Jääskeläinen
Datos Biográficos
| ID | 4618632 |
|---|---|
| NOMBRE | Erika Jääskeläinen |
| NOMBRES | Erika |
| APELLIDO | Jääskeläinen |
| FIRMA | JÄÄSKELÄINEN E |
| AFILIACIONES | University of Oulu |
| ORCID | 0000-0001-5760-7389 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 5 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 5 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2016 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2024 |
| ÍNDICE H | 0 |
Associations of lipids in adolescence and adulthood with self‐ and other‐directed compassion in adulthood
Self‐ and other‐directed compassion have been linked with better mental and physical health but research on factors contributing to their development is scarce. Previous studies indicate a possible causal relationship of lipids with personality and socioemotional functioning. As an extension to earlier research, in the present study we examine whether lipids assessed in adolescence and adulthood are associated with self‐compassion and other‐direc…
Mental disorder symptoms and diagnoses are differently associated with labour market attachment and registered income until midlife
Background: Both the symptoms and diagnoses of mental health disorders affect individuals’ occupational status and income. However, studies that compare the impact of differences between symptoms and diagnoses on occupational outcomes are lacking. Aims: This study aimed to compare labour market attachment and income until midlife between individuals with different histories of mental disorder symptoms and diagnoses. Method: Utilizing the Northern…
Results of the m-Resist feasibility study. A Mobile therapeutic attention for treatment-resistant schizophrenia
The International Journal of Integrated Care (IJIC) is an online, open-access, peer-reviewed scientific journal that publishes original articles in the field of integrated care on a continuous basis.IJIC has an Impact Factor of 5.120 (2020 JCR, received in June 2021)
M-Resist, a modular intervention programme addressed to patients with treatment-resistant schizoprenia
In European Union, between 0.2 and 2.6% of the population suffer from psychotic disorders (Wittchen et al., 2011). The largest group is patients with schizophrenia, and around 40% can be considered resistant to pharmacological treatment (Essock et al., 1996; Kennedy et al., 2014). Standard intervention in patients with treatment-resistant schizophrenia (TRS) is difficult due to the persistence of positive symptoms, extensive periods of hospitaliz…
An innovative and integrative m-Health solution for treatment resistant schizophrenia patients
In the European Union, it is estimated that around 5 million people (0.2-2.6%) suffer from psychotic disorders. Between 30-50% can be considered resistant to treatment, and 10-20% ultra-resistant (Juarez-Reyes et al., 1995; Essock et al., 1996). The standard intervention in patients with resistant schizophrenia is complex, mainly for the presence of persistent positive symptomatology, extensive periods of hospital care and greater risk of multi-m…
Sin obras prominentes en esta página.
An innovative and integrative m-Health solution for treatment resistant schizophrenia patients
In the European Union, it is estimated that around 5 million people (0.2-2.6%) suffer from psychotic disorders. Between 30-50% can be considered resistant to treatment, and 10-20% ultra-resistant (Juarez-Reyes et al., 1995; Essock et al., 1996). The standard intervention in patients with resistant schizophrenia is complex, mainly for the presence of persistent positive symptomatology, extensive periods of hospital care and greater risk of multi-m…
M-Resist, a modular intervention programme addressed to patients with treatment-resistant schizoprenia
In European Union, between 0.2 and 2.6% of the population suffer from psychotic disorders (Wittchen et al., 2011). The largest group is patients with schizophrenia, and around 40% can be considered resistant to pharmacological treatment (Essock et al., 1996; Kennedy et al., 2014). Standard intervention in patients with treatment-resistant schizophrenia (TRS) is difficult due to the persistence of positive symptoms, extensive periods of hospitaliz…
Results of the m-Resist feasibility study. A Mobile therapeutic attention for treatment-resistant schizophrenia
The International Journal of Integrated Care (IJIC) is an online, open-access, peer-reviewed scientific journal that publishes original articles in the field of integrated care on a continuous basis.IJIC has an Impact Factor of 5.120 (2020 JCR, received in June 2021)
Associations of lipids in adolescence and adulthood with self‐ and other‐directed compassion in adulthood
Self‐ and other‐directed compassion have been linked with better mental and physical health but research on factors contributing to their development is scarce. Previous studies indicate a possible causal relationship of lipids with personality and socioemotional functioning. As an extension to earlier research, in the present study we examine whether lipids assessed in adolescence and adulthood are associated with self‐compassion and other‐direc…
Mental disorder symptoms and diagnoses are differently associated with labour market attachment and registered income until midlife
Background: Both the symptoms and diagnoses of mental health disorders affect individuals’ occupational status and income. However, studies that compare the impact of differences between symptoms and diagnoses on occupational outcomes are lacking. Aims: This study aimed to compare labour market attachment and income until midlife between individuals with different histories of mental disorder symptoms and diagnoses. Method: Utilizing the Northern…
Medicine (4 obras) · Psychiatry (4 obras) · Digital Mental Health Interventions (3 obras) · Schizophrenia (object-oriented programming (3 obras) · Intervention (counseling (2 obras) · Mobile Health and mHealth Applications (2 obras) · Psychological intervention (2 obras) · Psychosocial (2 obras) · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (1 obras) · Asymptomatic (1 obras)